Fred Hutchinson
Cancer Center
Foundational Partner | Seattle, Washington
If you're an HR or benefits professional seeking cancer resources for your employees, or a consultant looking to provide best-in-class cancer support for your clients, share a few details below. We’ll reach out to help your company get started.
If you’re an employee looking for your AccessHope benefit, call 800.423.3232 and select Option 1.
Fred Hutchinson Cancer Center combines adult cancer care and advanced scientific research, and has a history of discoveries that treat, cure and identify prevention strategies for cancer and infectious diseases. The organization was renamed in April 2022, following the merger of long-time partners, Fred Hutchinson Cancer Research Center and Seattle Cancer Care Alliance. Fred Hutchinson Cancer Center is an independent, nonprofit organization that serves as UW Medicine’s cancer program.
Fred Hutch has been a National Cancer Institute-designated cancer center since 1973. Global leadership in bone marrow transplantation, HIV/AIDS, immunotherapy and COVID-19 helped Fred Hutch earn recognition as one of the world’s leading cancer, infectious disease and biomedical research centers. Based in Seattle, Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy and related services, and has network affiliations with hospitals in five states.
Fred Hutch is nationally ranked in 1 adult specialty and rated high performing in 6 adult procedures and conditions.
In the 1970s, a team of Fred Hutch scientists provided the first definitive and reproducible example of the immune system defeating cancer. Led by Dr. E. Donnall Thomas, they pioneered bone marrow transplantation as a treatment for previously incurable blood cancers which won Dr. Thomas the Nobel Prize and helped develop a new field of cancer treatment known as immunotherapy.
Fred Hutch is located in Seattle Washington and extends our coverage to the Pacific Northwest region of the United States.
As oncologic innovation continues to develop at an extraordinary pace, you can connect to our specialists with National Cancer Institute (NCI)–Designated Comprehensive Cancer Centers for no-cost support. If your patient is eligible for our employee benefit of cancer support services through their employer, our subspecialists can provide ever-evolving expertise on the latest advancements in their specific cancer.
01/31/23 -
Fred Hutchinson Cancer Center releases two new studies that reveal how bacteria infiltrate tumors and how they could be helping tumors progress and spread. The studies focused on an oral bacterium called Fusobacterium nucleatum, which has been linked to colorectal cancer. The studies suggest that tumor microbiota may shape tumor development, progression, and response to treatment. Read more
City of Hope is a world renowned cancer research and treatment center based in southern California. It is a National Cancer Institute-designated comprehensive cancer center, in addition to being a founding member of the National Comprehensive Cancer Network, making it a national leader in advancing research and treatment protocols. For over a decade, City of Hope has been identified as one of the nation’s elite cancer hospitals by U.S. News & World Report.
Dana-Farber Cancer Institute in Boston, MA is a Harvard Medical School teaching hospital. It is the #1 ranked cancer hospital in New England by US News & World Report. Nationwide, it is the only cancer hospital to be ranked in the top 5 for both adult and pediatric oncology care. Dana-Farber is dedicated to a unique balance of cancer care and research, translating discovery into new therapies for patients around the world and offering more than 1,100 clinical trials.
Dana-Farber is a founding member of the Dana-Farber/Harvard Cancer Center (DF/HCC), an NCI-designated Comprehensive Cancer Center, a founding member of the National Comprehensive Cancer Network, the top academic recipient of grant funding from the National Cancer Institute (NCI), and has the most highly cited research of any U.S. cancer center.
Emory Healthcare, with more than 24,000 employees and 11 hospitals, is the most comprehensive academic health system in Georgia. System-wide, it has 2,796 licensed patient beds, more than 2,800 physicians practicing in more than 70 specialties, serving metro Atlanta with 250 locations. It also provides services to greater Georgia through a joint venture at St. Francis–Emory Healthcare Hospital in Columbus, 10 regional affiliate hospitals, and its clinically integrated physician network.
As the National Cancer Institute (NCI)-designated comprehensive cancer center for the state of Georgia, Winship Cancer Institute of Emory University discovers, develops and delivers some of the world's most effective ways to prevent, detect, diagnose and treat each patient's unique cancer. Winship leverages the depth and breadth of Emory University and collaborates with other NCI-designated cancer centers and leading cancer organizations. Winship investigators conducted more than 300 therapeutic clinical trials and enrolled more than 900 patients in 2020. Winship has more than 500 faculty and received $80 million in cancer research funding in 2020, $33 million of that from the NCI.
Northwestern Medicine is a nationally recognized health system that provides world-class care. Anchored by Northwestern Memorial Hospital, ranked No. 1 in Illinois and No. 9 in the nation by US News and World Report. Northwestern Medicine encompasses more than 200 locations including 10 hospitals, the Northwestern University Feinberg School of Medicine and The Robert H. Lurie Comprehensive Cancer Center.
Backed by the Lurie Cancer Center, Northwestern Memorial Hospital is ranked #9 in the nation by US News and World Report and is part of a select group of National Cancer Institute (NCI) designated Comprehensive Cancer Centers. Dedicated to overcoming cancer through scientific discovery, the Lurie Cancer Center provides compassionate, leading edge cancer care in a state of the art facility.
Fred Hutchinson Cancer Center combines adult cancer care and advanced scientific research, and has a history of discoveries that treat, cure and identify prevention strategies for cancer and infectious diseases. The organization was renamed in April 2022, following the merger of long-time partners, Fred Hutchinson Cancer Research Center and Seattle Cancer Care Alliance. Fred Hutchinson Cancer Center is an independent, nonprofit organization that serves as UW Medicine’s cancer program.
Fred Hutch has been a National Cancer Institute-designated cancer center since 1973. Global leadership in bone marrow transplantation, HIV/AIDS, immunotherapy and COVID-19 helped Fred Hutch earn recognition as one of the world’s leading cancer, infectious disease and biomedical research centers. Based in Seattle, Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy and related services, and has network affiliations with hospitals in five states.
As part of the Johns Hopkins Medicine academic health system and Johns Hopkins University School of Medicine, the Kimmel Cancer Center has five locations in the Baltimore and Greater Washington, D.C., regions. Designated by the National Cancer Institute as one of the first comprehensive cancer centers in the country, its physicians and scientists are recognized leaders throughout the nation and the world.
The Kimmel Cancer Center understands that each patient is unique and it provides a tailored approach to care by multidisciplinary teams of specialists. Its patients have access to a large number of clinical trials and supportive care resources for themselves and their caregivers. From immunotherapy and proton therapy, to molecular tumor board-guided treatments, its physicians, nurses, and pharmacists are dedicated to providing the best care possible backed by innovative research.
UT Southwestern Medical Center Partners with AccessHope to extend nationwide access to cancer expertise